Hemp drink sales at Seattle Hempfest marks an emerging trend
Abattis Bioceuticals’ (OTCQX: ATTBF | CSE: ATT) is making good on its promises to deploy innovative market applications in the cannabis industry. Abattis reported the sale of 10,000 500 ml bottles of hemp-infused drinking water as a result of its ongoing natural health product research and development efforts. The water was sold to Nana’s Secret Soda of Washington State by Vergence Visionary Bioceuticals, wholly-owned subsidiary of Abattis focused on the sales and marketing of Abattis natural health products..
Abattis CEO Bill Fleming reported that the product has received excellent feedback and out at the Seattle Hempfest, which was held on August 14-16, 2015.
Get our daily investorintel update
The 24rd Annual Seattle Hempfest took place August 14-16, 2014. Attendance in 2015 is not available yet but the 2014 numbers show 120,000 visitors.
Devoid of THC, hemp food products have been clinically studied and have been praised for a wide spectrum of health benefits which include: lowering blood pressure by reducing inflammation and improving circulation, improving cholesterol levels, improving digestion, promoting weight loss and so on and so forth.
The emergence of hemp drinks, particularly drinks enhanced with CBD, in the marketplace marks three significant market, legislative and consumer trends:
- Drinks based on the use of hemp extracts are a part of a trend for the reviving of the hemp industry that offers a tantalizing area for market expansion: Industrial hemp is marketed a fiber, as a seed, or as a dual-purpose crop. Although detailed market information for hemp in not readily available, estimates from The Hemp Industries Association (HIA) show that the total retail value of hemp products in the U.S. in 2013 was $581 million. This includes food and body products, clothing, auto parts, building materials, and other products.
- A shifting legislative framework also supports hemp drinks. Last month, the Supreme Court of Canada ruled that the consumption of medicinal marihuana and other extracts and derivatives is no longer limited to smoking; legalizing all means of medicinal marihuana consumption in one fell swoop. The Supreme Court’s ruling had the intrinsic effect of forcing the revision of the current MMPR regulations (Marihuana for Medicinal Purposes Regulations) in which the consumption of edibles is illegal.
- The marijuana/hemp market is showing new consumer preference markets for marihuana and hemp derivative products. For example, in a study prepared for the Colorado Department of Revenue, The Marijuana Policy Group (MPG) describe the slow, but steady shift away from smoking marihuana, the traditional way of consuming marihuana, to alternative methods such as edibles, vaporizers, concentrates, lotions and salves.
Among its many partnerships and agreements Abattis counts five divisions, which enhance the Company’s strategically cultivated network spanning the entire industry.
- Biocube Green Grow Systems Corp., a wholly owned subsidiary of Abattis provides controlled cannabis cultivation environments for high yield marijuana growing. It recently entered into a worldwide non-exclusive licensing agreement with TerraSphere Systems LLC (“TerraSphere”) for the company’s proprietary and patented vertical farming technology. The TerraSphere license complements Biocube’s previously announced sublicensing agreement for Vertical Design Ltd.’s (“VDL”) vertical farming technology. The patented technology intends to increase plant production tenfold through unique vertical design components applicable in any hydroponic greenhouse setting.
- iJuana Inc. also a wholly owned subsidiary of Abattis is directly involved with the goal of becoming a licensed producer under Canada’s MMPR. The company aims to become the licensed cannabis-growing arm and consumer-facing entity for Abattis Bioceuticals.
- Biocell Labs Inc., also a wholly owned subsidiary of the Company focuses on supplying standardized pharmaceutical grade products. Currently, the company has 13 proprietary formulations for out-licensing to cosmetic, nutraceutical and pharmaceutical companies. BioCell Labs, Inc. reached strategic agreements with Empirical Labs of Ft Collin, Colorado for unique liposome technology; molecules relating to nutrient absorption. The Company has been further active on this end and in February 2015 announced their agenda to deliver Hemp-based nutraceutical supplements to the licensed health care provider marketplace.
- North American Bioextracts Inc. is the wholly owned retail distribution arm of Abattis operating in Canada and Washington State and it focuses on cannabis, cannabis derivatives, and ancillary products like vaporizers where legally permitted. North American Bioextracts can be seen as the Company’s distribution arm, which helps grow operations and ultimately spurr the industry forward.
- Northern Vine Canada Inc. applied for a Controlled Substance Licensee with Health Canada but also augments the Company’s presence throughout the industry by providing services pertaining to cannabis processing, testing and packaging. In an industry struggling to develop industry-wide Quality Control practices, Abattis has positioned itself at the forefront of these concerns with their 25% share exchange with Northern Vine Canada Inc.
Dr. Luc C. Duchesne is a Speaker and Author with a PhD in Biochemistry. With three decades of scientific and business experience, he has published ... <Read more about Dr. Luc Duchesne>